CS223441B1 - Antihelmintically active 1-/2-isobutylthio-6-benzothiazole laminimethyl/5-phenyl-1,2,3,4-tetrazole and method of making the same - Google Patents
Antihelmintically active 1-/2-isobutylthio-6-benzothiazole laminimethyl/5-phenyl-1,2,3,4-tetrazole and method of making the same Download PDFInfo
- Publication number
- CS223441B1 CS223441B1 CS165682A CS165682A CS223441B1 CS 223441 B1 CS223441 B1 CS 223441B1 CS 165682 A CS165682 A CS 165682A CS 165682 A CS165682 A CS 165682A CS 223441 B1 CS223441 B1 CS 223441B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- isobutylthio
- tetrazole
- phenyl
- active
- laminimethyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Vynález sa týká l-(2-izobutyltio-6-benzotiazolylaminiometyl)5-fenyl-l,2,3,4-tetrazolu vzorca I CW3 S c>»-'v-ogrThe invention relates to l- (2-isobutylthio-6-benzotiazolylaminiometyl) 5-phenyl-l, 2,3,4-tetrazole of formula I, CW 3 S C> »- 'in-OGR
NH-CHfN'' Z χ NH-CH 2 N 2 Z χ
C~N (Π a spósobu jeho- přípravy. Uvedená zlúčenina nebola doteraz v literatúre popísaná. Zlúčenina je antihelininticky účinná na Heterakis spumosa. Podstata spósobu přípravy 1- (2-izobutyltio-6 -benzotiazolylaminometyl) 5-fenyl-l,2,3,4-tetraznlu spočívá v tom, že 2-izobutyltio-6-aminobenzo'tiazol reaguje s formaldehydom a 5-fenyl-l,2,3,4-tetrazolom Mannichovou syntézou, podlá reakčnej schémy:The compound is antihelinintically active on Heterakis spumosa. The essence of the process for preparing 1- (2-isobutylthio-6-benzothiazolylaminomethyl) 5-phenyl-1,2,3 4-tetrazole is characterized in that 2-isobutylthio-6-aminobenzoothiazole is reacted with formaldehyde and 5-phenyl-1,2,3,4-tetrazole by Mannich synthesis according to the reaction scheme:
Syntéza sa uskutečňuje zmiešaním 2-izobutyltio-6-aminobenzotiazolu (E. Sidóová a Ž. Odlerová: Autorské osvedčenie číslo 189 212-78) s 5-íenyl-l,2,3,4-tetrazolom (F. Považanec, J. Kováč a A. Krutošíková: Collection Czech. Chem. Commun., 41, 1692, 1976) v prostředí alkoholu Ci až C3 a následným přidáním fofmaldehydu za miešania v rozmedzí od lahoratórnej teploty do 40 °C. !The synthesis is carried out by mixing 2-isobutylthio-6-aminobenzothiazole (E. Sidóová and Ž. Odlerová: Certificate of Authorization No. 189 212-78) with 5-phenyl-1,2,3,4-tetrazole (F. Považanec, J. Kováč) and A. Krutošíková: Collection Czech. Chem. Commun., 41, 1692, 1976) in a C 1 -C 3 alcohol medium followed by the addition of fofmaldehyde with stirring ranging from a lahora temperature to 40 ° C. !
Predmet vynálezu · ilustruje nasledujúci příklad:The subject of the invention is illustrated by the following example:
11,5 g (0,05 mol) 2-izobutyltio-6-aminobenzotiazolu sa zmieša za lahoratórnej teploty so 7,5 g (0,05 múl) 5-fenyl-l,2,3,4-tetrazolu. Prileje sa 100 ml etanolu (96%) a za mlešania sa zmes zohreje na 35 °C. Pri tejto teplote sa do roztoku přidává po častiach 10 ml (0,10 mol) íormaldehydu (30%) takou rýchlosťou, aby sa teplota zmesi udržíavala v rozmedzí 35 až 40 °C. Po 30 minútach od prldania íormaldehydu sa za nepřerušeného miešania přidá do zmesi pri 0 QC až —10 °C, 5 ml vody, dalej 20 ml acetonu a připadne 100 ml petroléteru. Po 5 minútach miešania pri teplote 35 až 40 °C sa zmes uloží pri teplote —20° až —30 °C po dobu 24 hodin. Vykrystalizovaný produkt sá za chladu odsaje na Buchnerovom lieviku, na ktorom sa premyje 20 ml petroléteru, ochladeného· na — 20 °C. Odsávanie sa přeruší po 10 minútach od zohriatia Bíichnerovho lievika s finálnou látkau na okolitú teplotu. Po vysušení sa získá 13,8 g látky I, čo představuje 70% výťažok oproti teorii.11.5 g (0.05 mol) of 2-isobutylthio-6-aminobenzothiazole are mixed with 7.5 g (0.05 mol) of 5-phenyl-1,2,3,4-tetrazole at ambient temperature. 100 ml of ethanol (96%) are added and the mixture is heated to 35 ° C while stirring. At this temperature, 10 ml (0.10 mol) of formaldehyde (30%) is added portionwise to the solution at a rate such that the temperature of the mixture is maintained at 35-40 ° C. After 30 minutes from prldania formaldehyde feeds the uninterrupted under stirring to the mixture at 0 Q C to -10 ° C, 5 mL of water followed by 20 mL of acetone and 100 ml of petroleum ether optionally. After stirring for 5 minutes at 35 to 40 ° C, the mixture was stored at -20 ° to -30 ° C for 24 hours. The crystallized product is suction filtered off with suction on a Buchner funnel, where it is washed with 20 ml of petroleum ether cooled to -20 ° C. The suction is discontinued 10 minutes after the Bichner funnel with the final substance has been brought to ambient temperature. After drying, 13.8 g of compound I is obtained, which is a 70% yield over theory.
1- (2-izobutyltio-6-benzotiazolylaminometyl)5-fenyl-l,2,3,4-tetrazol je krystalická látka, svetlošedej farby, rozpustná v dimetylformamide alebo dimetylsulfoxide, neroz4 pustná je vo vodě. Topí sa pri teplote 137 až 139 °C.1- (2-isobutylthio-6-benzothiazolylaminomethyl) 5-phenyl-1,2,3,4-tetrazole is a crystalline substance, light gray in color, soluble in dimethylformamide or dimethylsulfoxide, insoluble in water. Melting at 137-139 ° C.
Sumárny vzorec: C19H20N6S2.Summary formula: C19H20N6S2.
Molekulová hmotnost: 396,54.Molecular Weight: 396,54.
Elementárna analýza:Elemental analysis:
teórie:theory:
57,55 % C, 5,08 % H, 21,19 % N, 16,17 % S, zistené:C 57.55, H 5.08, N 21.19, S 16.17, found:
57,90 % C, 5,14 % H, 21,38 % N, 16,22 % S.% H, 5.14;% N, 21.38;% S, 16.22.
Efektivnost 1- (2-izobutyltio-6-benzodiazolylaminometyl) 5-fenyl-l,2,3,4-tetrazolu na Heterakis spumosa:Effectiveness of 1- (2-isobutylthio-6-benzodiazolylaminomethyl) 5-phenyl-1,2,3,4-tetrazole on Heterakis spumosa:
Heterakis spumosa je modelový helmint adaptovaný na myši a potkanov. Slúži ako model pre črevné nematódy. Je jedným zo 6 modelov, na ktorých sa testujú novosyntetizované látky. Tento model je užívaný aj výrobeami antihelmintík ako sú Hoechst A. G. a Bayer A. G.Heterakis spumosa is a model helminth adapted to mice and rats. It serves as a model for intestinal nematodes. It is one of 6 models to test newly synthesized substances. This model is also used in the manufacture of anthelmintics such as Hoechst A. G. and Bayer A. G.
Biele myši SPF kmeňa boli experimentálně invadované 100 vajíčkami Heterakis spumosa. 42. deň po experimentálnej invázii boli myši liečené látkou podía vynálezu, per os v dávke 150 mg/kg po dobu 3 dní. 50. deň p. i. boli zvieratá usmrtené a bola urobená helmintologická pitva bečených zvierat a kontrolných zvierat. Všetky 4 liečené zvierata boli negativné na Heterakis spumosa, kým· kontrolná skupina bola silné invadovaná.White mice of the SPF strain were experimentally invaded with 100 Heterakis spumosa eggs. On day 42 after experimental invasion, mice were treated with the compound of the invention orally at 150 mg / kg for 3 days. On day 50 p.i., the animals were sacrificed and a helminthological autopsy was performed on the animals and control animals. All 4 treated animals were negative for Heterakis spumosa while the control group was heavily invaded.
Látka podía vynálezu vykázala na Heterakis spumosa 100% efektivnost v I. sérii pokusov.The compound of the invention showed 100% efficacy on Heterakis spumosa in the first series of experiments.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS165682A CS223441B1 (en) | 1982-03-11 | 1982-03-11 | Antihelmintically active 1-/2-isobutylthio-6-benzothiazole laminimethyl/5-phenyl-1,2,3,4-tetrazole and method of making the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS165682A CS223441B1 (en) | 1982-03-11 | 1982-03-11 | Antihelmintically active 1-/2-isobutylthio-6-benzothiazole laminimethyl/5-phenyl-1,2,3,4-tetrazole and method of making the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS223441B1 true CS223441B1 (en) | 1983-10-28 |
Family
ID=5351471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS165682A CS223441B1 (en) | 1982-03-11 | 1982-03-11 | Antihelmintically active 1-/2-isobutylthio-6-benzothiazole laminimethyl/5-phenyl-1,2,3,4-tetrazole and method of making the same |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS223441B1 (en) |
-
1982
- 1982-03-11 CS CS165682A patent/CS223441B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2656374C2 (en) | ||
| SU1373318A3 (en) | Method of producing pyrrolidinone derivatives or acid-additive salts thereof | |
| IL26686A (en) | 6-amino-1,2-dihydro-1-hydroxy-2-imino-pyrimidines and process for their preparation | |
| DE2504565A1 (en) | NEW DERIVATIVES OF 1H-IMIDAZO (4,5-C) PYRIDINE-7-CARBOXYLIC ACIDS AND ACID ESTERS | |
| FI74705C (en) | Process for the preparation of new crystalline benzothiazine dioxide salts. | |
| EP0011399A1 (en) | N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them | |
| DE60313895T2 (en) | 2,7-DISUBSTITUTED USES AND THEIR USE AS 5-HT6 MODULATORS | |
| DE1470296A1 (en) | Process for the preparation of therapeutically active 1,2-dihydro-1,2,4-benzotriazines | |
| DE2454632A1 (en) | NEW 5(6)-SUBSTITUTED BENZIMIDAZOLE-2-CARBAMATS AND THEIR PRODUCTION | |
| RU2162081C2 (en) | Method of synthesis of lamotrigine and intermediate compound used for its synthesis | |
| IE47417B1 (en) | Pyridine derivative | |
| CS223441B1 (en) | Antihelmintically active 1-/2-isobutylthio-6-benzothiazole laminimethyl/5-phenyl-1,2,3,4-tetrazole and method of making the same | |
| EP0066774B1 (en) | 1,4,9,10-tetrahydropyrazolo(4,3-e)pyrido(3,2-b)(1,4)diazepin-10-ones, process for their preparation and medicinal preparations containing them | |
| DE2708828A1 (en) | PURINE, THE PROCESS FOR THEIR MANUFACTURING AND PHARMACEUTICAL PREPARATIONS | |
| EP0072954B1 (en) | Isoindolin-2-yl-amino-imidazolines and isoindolin-2-yl guanidines, process for their preparation and their use as medicines | |
| DE1927759A1 (en) | New basic derivatives of benzoxazolin-2-one and process for making same | |
| DE2156637A1 (en) | Purine sugar derivatives, process for their preparation and their use | |
| DE2433308A1 (en) | PROCESS FOR PRODUCING NEW HETEROCYCLIC COMPOUNDS | |
| CA1132562A (en) | Halogeno derivatives of isopropylamino pyrimidine, their preparation and therapeutic use | |
| NL8502899A (en) | 6-PHENETHYLAMINOALKYL-FURO (3,4-C) -PYRIDINE DERIVATIVES, METHODS FOR PREPARING THESE DERIVATIVES AND THERAPEUTIC PREPARATIONS CONTAINING THEM. | |
| US3825533A (en) | N-carboxymethyl-n-substituted glycinate esters of 3-hydroxy-1,4-benzo-diazepin-2-ones | |
| DE1801205A1 (en) | Aminoalkylated thioether of 2-mercaptoindoles and process for their preparation | |
| DE2453212A1 (en) | 3-DISUBSTITUTED AMINOISOTHIAZOLE SQUARE BRACKET ON 3.4 SQUARE BRACKET FOR PYRIMIDINE | |
| DE69231244T2 (en) | PYRAZOLOTHIAZOLOPYRIMIDINE DERIVATIVES | |
| DE2114441A1 (en) | Benzodiazepindenvates and processes for their preparation |